News|Videos|July 29, 2026

Oncology PulsePoint: How Updated Immunotherapy Guidelines are Changing Renal Cell Carcinoma Care

Author(s)Angie Maynard, PharmD, MS, BCOP, Ryu Kariyawasam-Chavez, Content Associate

Angie Maynard, PharmD, MS, BCOP, discusses RCC immunotherapy guidelines, treatment selection, toxicity management, and pharmacists’ clinical role.

In an interview with Pharmacy Times, Angie Maynard, PharmD, MS, BCOP, discussed key updates to the Society for Immunotherapy of Cancer clinical practice guidelines for immunotherapy in renal cell carcinoma, with a primary focus on clear cell renal cell carcinoma.